Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Metab Brain Dis ; 38(1): 17-44, 2023 01.
Article in English | MEDLINE | ID: mdl-35960461

ABSTRACT

Alzheimer's disease (AD) is the common type of dementia and is currently incurable. Existing FDA-approved AD drugs may not be effective for everyone, they cannot cure the disease nor stop its progression and their effects diminish over time. Therefore, the present review aimed to explore the role of natural alternatives in the treatment of AD. A systematic search was conducted using Ovid MEDLINE, CINAHL, Cochrane and PubMed databases and reference lists up to November 30, 2021. Only randomized control trials were included and appraised using the National Institute of Health framework. Data analysis showed that herbs like Gingko Biloba, Melissa Officinalis, Salvia officinalis, Ginseng and saffron alone or in combination with curcumin, low-fat diet, NuAD-Trail, and soy lecithin showed significant positive effects on AD. Moreover, combination of natural and pharmaceuticals has far better effects than only allopathic treatment. Thus, different herbal remedies in combination with FDA approved drugs are effective and more promising in treatment of AD.


Subject(s)
Alzheimer Disease , Phytotherapy , Plants, Medicinal , Humans , Alzheimer Disease/drug therapy , Alzheimer Disease/therapy , Randomized Controlled Trials as Topic
2.
PLoS One ; 17(10): e0276236, 2022.
Article in English | MEDLINE | ID: mdl-36302045

ABSTRACT

INTRODUCTION: Diabetes mellitus is a chronic metabolic disorder with an increasing prevalence worldwide. Reduction in blood insulin level alters brain function by inducing oxidative stress with changes in dopamine and norepinephrine neurotransmission, ultimately leading to neuropsychological symptoms. The efficacy of currently available psychotropic drugs is not satisfactory. Therefore, this study was conducted to explore the beneficial effects of a combination of the natural herbs, saffron and chamomile, in treating diabetes and its resultant neuropsychological effects using a rodent model of diabetes mellitus. METHOD: The rats were randomly divided in to eight groups (n = 10), healthy control (HC), diabetic control (DC) and six groups of diabetic rats treated with various concentrations and combinations of saffron and chamomile. Diabetic treatment groups individually received methanolic extract and water decoction of chamomile (30 mg/kg) and saffron (10mg/kg) and their combined half doses (saffron 5mg/kg and chamomile 15mg/kg) for two weeks. Open field test (OFT) and forced swim test (FST) were used to measure the anxiolytic and antidepressant effects of herbs, respectively. Finally, biochemical, and neurochemical estimations were made. RESULTS: The present study suggests the therapeutic effects of herbs especially in co-administrated decoction, against diabetes with improved antioxidant profile and enhanced levels of dopamine and norepinephrine. Anxiolytic and antidepressant effects were evident with improvements in the OFT and FST. Examination of the cortex of the diabetic group revealed cellular damage and tangle formation, which indicates advanced stages of dementia. CONCLUSION: This study shows that the use of a combination of saffron and chamomile improves diabetes control and reduces its related psychiatric effects.


Subject(s)
Anti-Anxiety Agents , Crocus , Diabetes Mellitus, Experimental , Rats , Mice , Animals , Chamomile , Diabetes Mellitus, Experimental/metabolism , Anti-Anxiety Agents/therapeutic use , Disease Models, Animal , Dopamine/therapeutic use , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Antidepressive Agents/therapeutic use , Norepinephrine/therapeutic use
3.
Neurochem Res ; 46(12): 3273-3285, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34409523

ABSTRACT

Depressive state adversely affects the memory functions, especially in the geriatric population. The initial stage of memory deficits associated with depression is particularly called as pseudodementia. It is the starting point of memory disturbance before dementia. The purpose of this research was to study depression and its consequent pseudodementia. For this purpose 24 male albino Wistar rats were divided into four groups. Depression was induced by 14 days of chronic restraint stress (CRS) daily for 4 h. After developing a depression model, pattern separation test was conducted to monitor pseudodementia in rats. Morris water maze test (MWM) was also performed to observe spatial memory. It was observed that model animals displayed impaired pattern separation and spatial memory. Treatment was started after the development of pseudodementia in rats. Curcumin at a dose of 200 mg/kg was given to model rats for one week along with the stress procedure. Following the treatment with curcumin, rats were again subjected to the aforementioned behavioral tests before decapitation. Corticosterone levels, brain derived neurotrophic factor (BDNF) and neurochemical analysis were conducted. Model rats showed depressogenic behavior and impaired memory performance. In addition to this, high corticosterone levels and decreased hippocampal BDNF, 5-HT, dopamine (DA), and acetylcholine (ACh) levels were also observed in depressed animals. These behavioral biochemical and neurochemical changes were effectively restored following treatment with curcumin. Hence, it is suggested from this study that pseudodementia can be reversed unlike true dementia by controlling the factors such as depression which induce memory impairment.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Curcumin/pharmacology , Depression/drug therapy , Dopamine/metabolism , Factitious Disorders/prevention & control , Hippocampus/drug effects , Neurotransmitter Agents/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Brain-Derived Neurotrophic Factor/genetics , Corticosterone/metabolism , Depression/metabolism , Depression/pathology , Factitious Disorders/etiology , Factitious Disorders/metabolism , Factitious Disorders/pathology , Hippocampus/metabolism , Hippocampus/pathology , Male , Rats , Rats, Wistar , Stress, Physiological
4.
Life Sci ; 277: 119417, 2021 Jul 15.
Article in English | MEDLINE | ID: mdl-33794248

ABSTRACT

AIMS: Schizophrenia (SZ) is recognized as a neuropsychiatric disorder in humans with accelerated mortality and profound morbidity followed with impairments in social as well as vocational functioning. Though various antipsychotics are being considered as approved treatment therapy for the psychotic symptoms of SZ but they also exert adverse effects and also lack efficacy in treating full spectrum of the disorder. Spirulina platensis (blue-green algae), a nutritional supplement, constitutes a variety of multi-nutrients and possesses a large number of neuroprotective activities. Therefore, present experimental work was designed to evaluate the neuroprotective effects of spirulina in ameliorating the psychosis-like symptoms in dizocilpine-induced rat model of SZ. MATERIALS AND METHODS: The spirulina was tested as preventive and therapeutic regimen at the dose of 180 mg/kg. After pre- and post-treatment with spirulina, rats were subjected to behavioral assessments followed by biochemical and neurochemical estimations. Biomarkers including APO-E, RTN-4, TNF-α, and IL-6 were also estimated using ELISA. KEY FINDINGS: Present results showed that administration of spirulina not only improved behavioral deficits induced by dizocilpine but it also regulates neurotransmission, oligodendrocyte dysfunction and APO-E over expression. Moreover, it also restores the immune response dysfunction by reducing inflammatory cytokines. SIGNIFICANCE: Thus, from present findings it may be suggested that spirulina aids in ameliorating the psychosis-like symptoms induced by dizocilpine in animal model possibly via regulation of neurotransmission and other biomarkers that are extensively used to uncover the etiopathology of SZ. Hence, blue-green algae can be used as an effective therapy for preventive or therapeutic measures in SZ.


Subject(s)
Apolipoproteins E/metabolism , Gene Expression Regulation/drug effects , Neuroprotective Agents/pharmacology , Nogo Proteins/metabolism , Prefrontal Cortex/drug effects , Schizophrenia/prevention & control , Spirulina/physiology , Animals , Apolipoproteins E/genetics , Behavior, Animal/drug effects , Dietary Supplements , Disease Models, Animal , Male , Nogo Proteins/genetics , Oxidative Stress , Prefrontal Cortex/metabolism , Rats , Rats, Wistar , Schizophrenia/genetics , Schizophrenia/metabolism , Schizophrenia/pathology
5.
Neurochem Res ; 45(11): 2762-2774, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32918662

ABSTRACT

Noise has always been an important environmental factor that induces health problems in the general population. Due to ever increasing noise pollution, humans are facing multiple auditory and non-auditory problems including neuropsychiatric disorders. In modern day life it is impossible to avoid noise due to the rapid industrialization of society. Continuous exposure to noise stress creates a disturbance in brain function which may lead to memory disorder. Therefore, it is necessary to find preventive measures to reduce the deleterious effects of noise exposure. Supplementation of taurine, a semi essential amino acid, is reported to alleviate psychiatric disorders. In this study noise-exposed (100 db; 3 h daily for 15 days) rats were supplemented with taurine at a dose of 100 mg/kg for 15 days. Spatial and recognition memory was assessed using the Morris water maze and novel object recognition task, respectively. Results of this study showed a reversal of noise-induced memory impairment in rats. The derangements of catecholaminergic and serotonergic levels in the hippocampus and altered brain antioxidant enzyme activity due to noise exposure were also restored by taurine administration. This study highlights the importance of taurine supplementation to mitigate noise-induced impaired memory via normalizing the neurochemical functions and reducing oxidative stress in rat brain.


Subject(s)
Memory Disorders/drug therapy , Neuroprotective Agents/therapeutic use , Noise/adverse effects , Oxidative Stress/drug effects , Spatial Memory/drug effects , Taurine/pharmacology , Animals , Male , Morris Water Maze Test/drug effects , Open Field Test/drug effects , Rats, Wistar , Recognition, Psychology/drug effects
6.
Sci Rep ; 10(1): 11206, 2020 07 08.
Article in English | MEDLINE | ID: mdl-32641780

ABSTRACT

Glutamate (Glu), the key excitatory neurotransmitter in the central nervous system, is considered essential for brain functioning and has a vital role in learning and memory formation. Earlier it was considered as a harmful agent but later found to be useful for many body functions. However, studies regarding the effects of free L-Glu administration on CNS function are limited. Therefore, current experiment is aimed to monitor the neurobiological effects of free L-Glu in male rats. L-Glu was orally administered to rats for 5-weeks and changes in behavioral performance were monitored. Thereafter, brain and hippocampus were collected for oxidative and neurochemical analysis. Results showed that chronic supplementation of free L-Glu enhanced locomotor performance and cognitive function of animals which may be attributed to the improved antioxidant status and cholinergic, monoaminergic and glutamatergic neurotransmission in brain and hippocampus. Current results showed that chronic supplementation of L-Glu affects the animal behaviour and brain functioning via improving the neurochemical and redox system of brain. Free L-Glu could be a useful therapeutic agent to combat neurological disturbances however this requires further targeted studies.


Subject(s)
Brain Chemistry/drug effects , Glutamic Acid/administration & dosage , Hippocampus/drug effects , Locomotion/drug effects , Memory/drug effects , Administration, Oral , Animals , Behavior, Animal , Brain Chemistry/physiology , Dietary Supplements , Glutamic Acid/analysis , Glutamic Acid/metabolism , Hippocampus/chemistry , Hippocampus/physiology , Locomotion/physiology , Male , Memory/physiology , Models, Animal , Oxidation-Reduction/drug effects , Rats , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , gamma-Aminobutyric Acid/analysis , gamma-Aminobutyric Acid/metabolism
7.
Pak J Pharm Sci ; 33(4(Supplementary)): 1847-1853, 2020 Jul.
Article in English | MEDLINE | ID: mdl-33612469

ABSTRACT

Spirulina platensis (blue-green algae) is a nutritional supplement. It constitutes of high content of protein, antioxidants, various phytopigments and possesses neuroprotective activities. Schizophrenia (SZ) is recognized as a neuropsychiatric disorder in humans with a reduced lifespan followed with impairments in social as well as vocational functioning. Major psychotic symptoms of SZ cluster into three categories: positive, negative and cognitive dysfunctions. Dizocilpine recognized as one of the best drugs to mimic full spectrum of SZ can develop an animal model of the disorder. Various antipsychotics are considered as approved treatment therapy for the psychotic symptoms of SZ but they also exert adverse effects. Thus, there is an excessive need for novel treatment(s) with negligible adverse effects. Present study was designed to evaluate the neuroprotective effects of spirulina in ameliorating the psychosis- like symptoms in dizocilpine-induced rat model of SZ. Spirulina was tested at the dose of 180 mg/kg. Results showed that administration of spirulina improved behavioral deficits and combated the oxidative damage evident by a significant reduction in lipid peroxidation and increase in antioxidant level. Thus, from present findings it may be suggested that spirulina can be used as a therapy for preventive or therapeutic measures.


Subject(s)
Oxidative Stress/drug effects , Schizophrenia/drug therapy , Spirulina/chemistry , Animals , Antioxidants/pharmacology , Dietary Supplements , Disease Models, Animal , Lipid Peroxidation/drug effects , Male , Neuroprotective Agents/pharmacology , Rats , Rats, Wistar
8.
Pak J Pharm Sci ; 32(4(Supplementary)): 1893-1900, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31680089

ABSTRACT

Unpredictable chronic mild stress (UCMS) model is the most established method to study neurobiological mechanisms of depression. This work was intended to explore the efficacy of curcumin to revert the UCMS-induced oxidative burden and associated depression as well as potential of curcumin as an acetyl cholinesterase (AchE) inhibitor. Animals were initially grouped into control and curcumin (200mg/kg, p.o) and further subdivided into unstressed and stressed groups. Depression and anxiety were evaluated by forced swim test (FST) and light/dark transition (LDT) while memory function was assessed by passive avoidance test (PAT). Effect of curcumin on oxidative stress following UCMS was determined by measuring peroxidation of lipid (LPO) and antioxidant enzyme activities. AchE activity was also determined. Findings showed that curcumin supplementation significantly attenuated the UCMS-induced depression and anxiety like symptoms, decreased the load of UCMS propagated oxidative stress by improving antioxidant enzymes activities. Curcumin also improved the memory function and exhibited inhibitory effect on AchE activity. In conclusion it can be suggested that supplementation of curcumin in daily life can help in combating the stress-induced depression and ever increasing load of oxidative stress. Study also highlights the anti-acetylcholinesterase potential of curcumin which may be responsible for improved memory function following UCMS.


Subject(s)
Acetylcholinesterase/metabolism , Cholinesterase Inhibitors/pharmacology , Curcumin/pharmacology , Depression/drug therapy , Memory Disorders/drug therapy , Oxidative Stress/drug effects , Stress, Psychological/drug therapy , Animals , Antioxidants/pharmacology , Anxiety/drug therapy , Anxiety/metabolism , Depression/metabolism , Lipid Peroxidation/drug effects , Male , Maze Learning/drug effects , Memory/drug effects , Memory Disorders/metabolism , Mice , Rats, Wistar , Stress, Psychological/metabolism
9.
Pak J Pharm Sci ; 32(1(Supplementary)): 277-283, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30829204

ABSTRACT

Magnesium (Mg) is an essential biomineral that acts as an intracellular cofactor for more than 300 enzymes. It is an important modulator of the N-methyl-D-aspartate (NMDA) receptor which is involved in memory function and depression. The purpose of this study was to compare the dose dependent effect of oral supplementation of Magnesium chloride (MgCl2), Magnesium sulphate (MgSO4) and Magnesium-L-threonate (MgT) on memory and depression-related behaviors in rats. Rats were orally administered with different doses (50 mg/kg, 100 mg/kg and 150 mg/kg) of each Mg salt. Following 28 days of oral supplementation, animals were subjected to behavioral tests. After completion of behavioral test, rats were decapitated. Brain and plasma samples were used for neurochemical and biochemical analysis. Assessment of behaviors in elevated plus maze (EPM) test and forced swim test (FST) showed that MgT more significantly improved memory of rats and decreased depression-like symptoms in healthy rats as compared to controls. Biochemical analysis indicated significant increase in plasma Mg levels dose dependently following MgT administration. This increase might be related to observe enhanced cholinergic functions and decline in oxidative stress in rats in the present study. This comparative study highlights that MgT (100mg/kg) is the most appropriate Mg salt and dose for oral treatment that strengthens cholinergic system and improves brain related functions through attenuation of oxidative burden in adult healthy rats.


Subject(s)
Brain/drug effects , Butyrates/pharmacology , Magnesium Chloride/pharmacology , Magnesium Sulfate/pharmacology , Memory/drug effects , Acetylcholine/metabolism , Animals , Behavior, Animal/drug effects , Brain/metabolism , Butyrates/administration & dosage , Depression/drug therapy , Dose-Response Relationship, Drug , Magnesium/blood , Magnesium Chloride/administration & dosage , Magnesium Sulfate/administration & dosage , Male , Rats, Wistar
10.
Plant Foods Hum Nutr ; 73(1): 7-12, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29429075

ABSTRACT

Scopolamine, an anti-muscarinic agent, has been shown to induce amnesia and oxidative stress similar to that observed in the older age. The present study was designed to determine the relationship between the oxidative status and memory improvement in scopolamine injected rats pre-administered with almonds. Rats (n = 8) in the almond group were administered orally with 400 mg/kg almond suspension for 28 days daily before the intraperitoneal injection of scopolamine (0.5 mg/kg). Passive avoidance task (PAT) was used to assess memory function at the end of treatment. The present study revealed that scopolamine injection significantly impaired the memory function in rats pre-treated with saline which was accompanied by increased oxidative stress as evident by increased brain malondialdehyde (MDA) levels and reduced activities of antioxidant enzymes as compared to healthy controls. Pre-treatment with almond significantly ameliorated scopolamine-induced oxidative stress and memory dysfunction. These findings suggest that dietary supplementation with almonds may have a beneficial effect in reducing the risk of oxidative stress-induced memory loss and delaying or preventing the onset of age-related memory impairment.


Subject(s)
Antioxidants/metabolism , Memory Disorders/diet therapy , Oxidative Stress/drug effects , Prunus dulcis/chemistry , Animals , Avoidance Learning/drug effects , Brain/drug effects , Brain/metabolism , Dietary Supplements , Dose-Response Relationship, Drug , Enzymes/metabolism , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Memory Disorders/chemically induced , Rats, Wistar , Scopolamine/toxicity
11.
Pak J Pharm Sci ; 30(1 Suppl): 273-279, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28625954

ABSTRACT

Excessive exposure of cadmium which is regarded as a neurotoxin can stimulate aging process by inducing abnormality in neuronal function. It has been reported that supplementation of almond and walnut attenuate age-related memory loss. Present study was designed to investigate the weekly administration of cadmium for one month on learning and memory function with relation to cholinergic activity. Cadmium was administered at the dose of 50 mg/kg/week. Whereas, almond and walnut was supplemented at the dose of 400 mg/kg/day along with cadmium administration to separate set of rats. At the end of experiment, memory function was assessed by Morris water maze, open field test and novel object recognition test. Results of the present study showed that cadmium administration significantly reduced memory retention. Reduced acetylcholine levels and elevated acetyl cholinesterase activity were also observed in frontal cortex and hippocampus of cadmium treated rats. Malondialdehyde levels were also significantly increased following the administration of cadmium. Daily supplementation of almond and walnut for 28 days significantly attenuated cadmium-induced memory impairment in rats. Results of the present study are discussed in term of cholinergic activity in cadmium-induced memory loss and its attenuation by nuts supplementation in rats.


Subject(s)
Cadmium/administration & dosage , Cholinergic Agents/administration & dosage , Habituation, Psychophysiologic/drug effects , Hippocampus/drug effects , Memory Disorders/chemically induced , Memory Disorders/diet therapy , Memory/drug effects , Acetylcholine/metabolism , Aging/drug effects , Animals , Dietary Supplements , Juglans , Maze Learning/drug effects , Prunus dulcis , Rats , Rats, Wistar
12.
Pharmacol Biochem Behav ; 159: 90-99, 2017 08.
Article in English | MEDLINE | ID: mdl-28642069

ABSTRACT

Choline, an essential nutrient, accounts for multiple functions in the body and brain. While its beneficial effects on healthy adults are not clear, choline supplementation is important during pregnancy for brain development, in elderly patients for support of cognitive performance and in patients with neurological disorders to reduce memory deficits. Thus, the aim of this study is to investigate whether choline administration in healthy adult rats beneficially impacts cognitive and locomotor performance, and associated oxidative and neurochemical outcomes. Two groups, control and choline, received tap water and choline bitartrate, respectively at the dose equivalent to adequate intake for five weeks. Food intake and body weight were monitored daily. Behavioral analysis comprising assessment of cognitive performance (by novel object recognition, passive avoidance and Morris Water Maze test) and locomotor performance (by Open field, Kondziela's inverted screen and beam walking test) were performed. Following testing, rats were decapitated and brain samples were collected for estimation of acetylcholine, redox profile and monoamine measurements. The results showed that chronic choline administration significantly improves cognitive and locomotor performance accompanied by a reduction in oxidative stress, enhanced cholinergic neurotransmission and monoamine levels in the brain of healthy adult rats. Hence, chronic choline intake was found to improve behavioral, oxidative and neurochemical outcomes in the normal population, so it can be suggested that choline tablets can be used as a safe and effective supplement for improving the neurological health of normal individuals and that they might also be beneficial in preventing cognitive and motor disorders later in life.


Subject(s)
Antioxidants/pharmacology , Brain Chemistry/drug effects , Choline/pharmacology , Cognition/drug effects , Nootropic Agents/pharmacology , Oxidative Stress/drug effects , Psychomotor Performance/drug effects , Acetylcholine/metabolism , Animals , Avoidance Learning/drug effects , Body Weight/drug effects , Dietary Supplements , Eating/drug effects , Maze Learning/drug effects , Rats , Rats, Wistar
13.
Pak J Pharm Sci ; 30(3(Suppl.)): 1013-1021, 2017 May.
Article in English | MEDLINE | ID: mdl-28655701

ABSTRACT

Glutamate (GLU) and gamma-amino butyric acid (GABA) are essential amino acids (AA) for brain function serving as excitatory and inhibitory neurotransmitter respectively. Their tablets are available in market for improving gut function and muscle performance. Despite of having a major role during memory formation and processing, effects of these tablets on brain functioning like learning and memory have not been investigated. Therefore, present study is aimed to investigate the effects of orally supplemented GLU and GABA on learning and memory performance and further to monitor related effects of these orally supplemented GLU and GABA on brain levels of these AA. Three groups of rats were supplemented orally with drinking water (control group) or suspension of tablets of GABA and Glutamate, respectively for four weeks. Cognitive performance was determined using behavioral tests (Novel object recognition test, Morris water maze, Passive avoidance test) measuring recognition, spatial reference and aversive memory. Levels of GLU, GABA and acetylcholine (ACh) were estimated in rat hippocampus. Results showed that chronic oral administration of GLU and GABA tablets has a significant impact on brain function and can alter GLU and GABA content in rat hippocampus. Compared to GABA, GLU supplementation specifically enhances memory performance via increasing ACh. Thus, GLU can be suggested as a useful supplement for improving learning and memory performance and neurochemical status of brain and in future could be effective in the treatment of neurological disorders affecting learning and memory performance.


Subject(s)
Brain Chemistry/drug effects , Glutamic Acid/pharmacology , Hippocampus/drug effects , Memory/drug effects , gamma-Aminobutyric Acid/pharmacology , Acetylcholine/metabolism , Animals , Cognition/drug effects , Dietary Supplements , Dose-Response Relationship, Drug , Glutamic Acid/administration & dosage , Glutamic Acid/pharmacokinetics , Hippocampus/chemistry , Hippocampus/metabolism , Maze Learning/drug effects , Rats, Wistar , Time Factors , gamma-Aminobutyric Acid/administration & dosage , gamma-Aminobutyric Acid/pharmacokinetics
14.
Brain Res Bull ; 120: 63-74, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26548495

ABSTRACT

Dietary nutrients may play a vital role in protecting the brain from age-related memory dysfunction and neurodegenerative diseases. Tree nuts including almonds have shown potential to combat age-associated brain dysfunction. These nuts are an important source of essential nutrients, such as tocopherol, folate, mono- and poly-unsaturated fatty acids, and polyphenols. These components have shown promise as possible dietary supplements to prevent or delay the onset of age-associated cognitive dysfunction. This study investigated possible protective potential of almond against scopolamine induced amnesia in rats. The present study also investigated a role of acetylcholine in almond induced memory enhancement. Rats in test group were orally administrated with almond suspension (400 mg/kg/day) for four weeks. Both control and almond-treated rats were then divided into saline and scopolamine injected groups. Rats in the scopolamine group were injected with scopolamine (0.5 mg/kg) five minutes before the start of each memory test. Memory was assessed by elevated plus maze (EPM), Morris water maze (MWM) and novel object recognition (NOR) task. Cholinergic function was determined in terms of hippocampal and frontal cortical acetylcholine content and acetylcholinesterase activity. Results of the present study suggest that almond administration for 28 days significantly improved memory retention. This memory enhancing effect of almond was also observed in scopolamine induced amnesia model. Present study also suggests a role of acetylcholine in the attenuation of scopolamine induced amnesia by almond.


Subject(s)
Memory Disorders/diet therapy , Prunus dulcis , Acetylcholine/metabolism , Acetylcholinesterase/metabolism , Animals , Disease Models, Animal , Frontal Lobe/metabolism , Hippocampus/metabolism , Maze Learning , Memory Disorders/metabolism , Random Allocation , Rats, Wistar , Recognition, Psychology , Scopolamine , Treatment Outcome
15.
Life Sci ; 124: 110-9, 2015 Mar 01.
Article in English | MEDLINE | ID: mdl-25637686

ABSTRACT

AIMS: D-Galactose (D-gal) induced accelerated senescence has been used to develop an aging model for brain. Previously, long term administration of a wide range of doses has been used for this purpose. In the present study we investigate whether short term administration of a high dose of D-gal in rats induces significant signs and symptoms similar to natural aging. MAIN METHODS: Young rats were injected intraperitoneally with D-gal at a dose of 300 mg/ml/kg for one week. Behavioral analysis for depression and anxiety like symptoms were monitored by forced swim test (FST) and light/dark transition (LDT) test. Assessment of memory was done using the Morris water maze (MWM), passive avoidance test (PAT) and elevated plus maze (EPM) test. Biochemical analysis was done for estimation of antioxidant enzymes and acetylcholinesterase. Determination of brain biogenic amines was performed by HPLC-EC. KEY FINDINGS: Short term administration of D-gal significantly altered behavioral, biochemical and neurochemical responses in rats. D-Gal injected rats exhibited depressogenic and anxiogenic behaviors while memory was also significantly impaired in these rats. Brain lipid peroxidation and superoxide dismutase activity were significantly increased while catalase and glutathione peroxidase decreased. Increased activity of acetylcholinesterase was also exhibited by D-gal injected rats while brain biogenic amines were significantly decreased. Food intake and growth rate were however comparable in both groups. SIGNIFICANCE: Together the behavioral, biochemical and neurochemical impairments following the high dose of D-gal suggest that symptoms similar to natural aging may be developed in rats in as early as one week.


Subject(s)
Aging/physiology , Behavior, Animal/physiology , Brain/physiology , Galactose/pharmacology , Memory/physiology , Acetylcholinesterase/metabolism , Animals , Antioxidants/metabolism , Biogenic Amines/metabolism , Catalase/metabolism , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Galactose/administration & dosage , Glutathione Peroxidase/metabolism , Lipid Peroxidation/physiology , Male , Maze Learning , Rats , Rats, Wistar , Time Factors
16.
Plant Foods Hum Nutr ; 66(4): 335-40, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22048906

ABSTRACT

Walnut has been regarded as a health food that is delicious and nutritious. Both preventive and therapeutic effects of walnut are well documented. Walnuts are rich in omega-3 fatty acids that are reported to have beneficial effects on brain function. The present work was designed to evaluate the effects of walnuts on learning and memory in male rats. The effect of oral intake of walnut was also monitored on food intake. Walnut was given orally to rats for a period of 28 days. Memory function in rats was assessed by elevated plus maze (EPM) and radial arm maze (RAM). A significant improvement in learning and memory of walnut treated rats compared to controls was observed. Walnut treated rats also exhibited a significant decrease in food intake while the change in growth rate (in terms of percentage) remained comparable between the two groups. Analysis of brain monoamines exhibited enhanced serotonergic levels in rat brain following oral intake of walnuts. The findings suggest that walnut may exert its hypophagic and nootropic actions via an enhancement of brain 5-HT metabolism.


Subject(s)
Juglans/chemistry , Maze Learning/drug effects , Memory/drug effects , Nootropic Agents/pharmacology , Administration, Oral , Animals , Body Weight/drug effects , Brain/drug effects , Brain/metabolism , Eating/drug effects , Male , Nervous System/chemistry , Nervous System/drug effects , Rats , Rats, Wistar , Serotonin/analysis , Serotonin/metabolism , Tryptophan/analysis , Tryptophan/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL